Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp (NCT06375811)
Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis - A Prospective Clinical Trial
🩺 Plain-English Summary (8th-Grade Level)
A Phase 3 clinical trial of oral GnRH antagonist pre-treatment for women with endometriosis who are undergoing IVF, with a primary outcome of live birth rate. The investigators' central hypothesis is that in infertile woman with endometriosis undergoing in vitro fertilization-embryo transfer (IVF-ET), live birth rates will improve in those pretreated with GnRH antagonist compared to those not pretreated with GnRH antagonist.
Who can join: Review the eligibility criteria below.
Location: University of Colorado Department of Obstetrics & Gynecology — Aurora, Colorado
Age range: 18 Years to 40 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (5 Sites)
- University of Colorado Department of Obstetrics & Gynecology — Aurora, Colorado
- Yale School of Medicine Dept.of Ob/Gyn & Reproductive Sciences — New Haven, Connecticut
- Northwestern University Department of Obstetrics and Gynecology — Chicago, Illinois
- Johns Hopkins, Division of Reproductive Science and Women's Health Research — Baltimore, Maryland
- Duke Fertility — Morrisville, North Carolina
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Infertility
- ANXA5 M2 Haplotyping in IVF Patients and Embryos — North Brunswick, New Jersey
- Fast Track to Fertility — Philadelphia, Pennsylvania
- Group Preconception Care for Fertility Patients — Philadelphia, Pennsylvania
- To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That Develop to the Point That They Are Able to be Transferred) in IVF Cycles. — Farmington, Connecticut
- Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield — Basking Ridge, New Jersey
Explore by condition: All Infertility clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.